❌

Normal view

Travere Therapeutics Turns a Rare Disease Approval into Two Quarters of Accelerating Sales

22 August 2026 at 12:48
The Food and Drug Administration granted Travere Therapeutics full approval for FILSPARI in focal segmental glomerulosclerosis on April 13, 2026, the drug’s second full approval after a 2023 clearance for IgA nephropathy. Travere’s stock rose 43 percent the next day, closing at $43.81.Β  The DUPLEX Data Behind a Second Approval FSGS damages the kidney’s filtering […]

NFTs vs Traditional Art Sales: Opportunities and Challenges

21 August 2026 at 10:25
Artists have sold their work through galleries, art fairs and auction houses to collectors worldwide for centuries: walk in, look at a piece and pay for something to hang on a wall. NFTs changed that. Now an artist can sell a digital file directly to a buyer anywhere in the world, with a blockchain tracking […]

Coders Say They Already Found Workarounds to Claude’s Invisible Watermarks

Anthropic announced last week it would include invisible watermarks in AI-generated content to comply with new EU rules. Within hours, overrides were being touted online.

OpenAI Overhauls Safety Protocols After Its AI Agents Went Rogue

The ChatGPT maker says its upcoming Astra model may have reached β€œcritical” cyber capabilities, prompting it to halt a significant number of training runs while it tightens internal safeguards.

Robot orders increase to $622 million in Q2 as automation demand broadens across industries

13 August 2026 at 10:09
New A3 data shows second-quarter growth across semiconductors/electronics, automotive components, food and consumer goods, metals and life sciences North American companies ordered 8,940 robots valued at $622 million in the second quarter of 2026, according to new data released by the Association for Advancing Automation (A3). Compared to the second quarter of 2025, this represents […]
❌